Cite
HARVARD Citation
Kimura, Y. et al. (2022). The TILs-US score on ultrasonography can predict the pathological response to neoadjuvant chemotherapy for human epidermal growth factor receptor 2-positive and triple-negative breast cancer. Surgical oncology. p. . [Online].